Madan Mohan Kwatra PhD

Dr. Madan Mohan Kwatra is an Associate Professor at Duke University Medical Center. His research focuses on the development of glioblastoma drugs personalized for each patient. Dr. Kwatra recently characterized a panel of patient-derived glioblastoma xenografts at the protein level, resulting in the identification of tumors with activated EGFR. Using these models, Dr. Kwatra is examining the preclinical efficacy of AZD9291, a drug recently approved by the FDA for lung cancer treatment, against a subset of glioblastoma tumors expressing activated EGFR. These studies are funded by the National Center for the Advancement of Translational Sciences (NCATS). Dr. Kwatra’s laboratory is also developing targeted therapies that target additional growth pathways identified by The Cancer Genome Atlas (TCGA) program.